Patrick Enright
Net worth: 53 M $ as of 2026-05-30
Net worth: 53 M $ as of 2026-05-30
Patrick G.
Enright founded Longitude Capital Management Co LLC in 2006, where he is working as Managing Director from 2006.
Mr. Enright also currently works at CuraSen Therapeutics, Inc., as Chairman from 2024, Veradermics, Inc., as Independent Director from 2024, Raven Biotechnologies, Inc., as Director, and various other companies.
Mr. Enright also formerly worked at Sequenom, Inc., as Director from 2006 to 2007, Esperion Therapeutics, Inc., as Independent Director from 2013 to 2016, Corcept Therapeutics, Inc., as Independent Director from 2011 to 2017, and various other companies.
Mr. Enright received his undergraduate degree in 1984 from Stanford University and Masters Business Admin degree in 1989 from The Wharton School of the University of Pennsylvania.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
4.15% | 2026-03-11 | 2,619,189 ( 4.15% ) | 48 M $ | 2026-05-30 |
| 2025-08-17 | 21,379 ( 0.03% ) | 5 M $ | 2026-05-30 | |
| 2026-05-20 | 5,882 ( 0.01% ) | 208 929 $ | 2026-05-30 | |
BIOAGE LABS, INC. -.--% | 2026-04-15 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| VERA THERAPEUTICS, INC. | Director/Board Member | 2020-10-31 |
| JAZZ PHARMACEUTICALS PLC | Director/Board Member | 2009-06-30 |
| BIOAGE LABS, INC. | Director/Board Member | 2024-01-31 |
| VERADERMICS, INCORPORATED | Director/Board Member | 2024-11-30 |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Director/Board Member | 2019-05-31 |
Lemo USA, Inc.
Lemo USA, Inc. Electronic ComponentsElectronic Technology Designs and manufactures custom connectors | Director/Board Member | 2011-12-31 |
Endeavor BioMedicines, Inc
Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage company that develops hedgehog inhibitor for Idiopathic pulmonary fibrosis | Director/Board Member | 2020-11-30 |
Opna Immuno-Oncology SA
Opna Immuno-Oncology SA BiotechnologyHealth Technology Engages in research and development of biotechnology products | Director/Board Member | 2022-05-31 |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops antibody therapeutics | Director/Board Member | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| Companies | Position | End |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 43 |
|---|---|
Valentis, Inc.
Valentis, Inc. Pharmaceuticals: MajorHealth Technology Develops products for urology indications | Health Technology |
Sequenom, Inc.
Sequenom, Inc. Medical/Nursing ServicesHealth Services Provides genomic and genetic analysis solutions | Health Services |
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Corcept Therapeutics, Inc.
Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
DiObex, Inc.
DiObex, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic disease treatment | Health Technology |
Tecan Genomics, Inc.
Tecan Genomics, Inc. Electronic Equipment/InstrumentsElectronic Technology Provides genomics sample preparation solutions | Electronic Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Codexis, Inc.
Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Health Technology |
CardioDx, Inc.
CardioDx, Inc. Medical/Nursing ServicesHealth Services Operates as a cardiovascular genomic diagnostics company | Health Services |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops antibody therapeutics | Commercial Services |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system | Health Technology |
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology Develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population | Health Technology |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Delta Opportunity Fund LLC | |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital invests in startup companies located in the United States, Canada and Europe primarily in New York and broader East Coast ecosystem. The firm focuses in consumer, enterprise and frontier technology sectors. It provides financing for early stage capital requirements. It acts as a lead investor. It also takes a seat on the board of directors. | Finance |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
National Venture Capital Association
National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
Horizon Therapeutics, Inc.
Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription drugs for mild to moderate pain relief | Health Technology |
Vaneltix Pharma, Inc.
Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for patients with urological ailments | Health Technology |
Boehringer Mannheim Pharmaceuticals Corp. | |
Longitude Capital Management Co LLC
Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital invests in both private and public companies located in the United States. The firm targets companies operating in the fields of medical technology, biotechnology and health solutions. It participates in early stage capital requirements. | Finance |
PaineWebber Development Corp. | |
Lemo USA, Inc.
Lemo USA, Inc. Electronic ComponentsElectronic Technology Designs and manufactures custom connectors | Electronic Technology |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Delevops products that treat rare diseases | Health Technology |
Aptinyx, Inc.
Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology Develops therapies obesity for metabolic diseases | Health Technology |
CuraSen Therapeutics, Inc.
CuraSen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel treatments for psychiatric and neurodegenerative diseases | Health Technology |
Rivus Pharmaceuticals, Inc.
Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Dascena, Inc.
Dascena, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical testing services | Commercial Services |
Pequot Capital Corp.
Pequot Capital Corp. Investment ManagersFinance Provides investment advisory services | Finance |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Veradermics, Inc.
Veradermics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company for treatment of dermatology and aesthetics problems | Health Technology |
Endeavor BioMedicines, Inc
Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage company that develops hedgehog inhibitor for Idiopathic pulmonary fibrosis | Commercial Services |
Opna Immuno-Oncology SA
Opna Immuno-Oncology SA BiotechnologyHealth Technology Engages in research and development of biotechnology products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions